Patents Examined by Ba K. Trinh
  • Patent number: 5466829
    Abstract: The present invention relates to new ginkgolide derivatives of the formula (I) as below which represents PAF-antagonistic activity and the method for the preparation thereof, by that the cyclic compounds of substituted Ginkgolide B derivatives are produced by reacting the known Ginkgolide B and C mixture having the hydroxy group in 1- and 10-carbon with acid, then they are separated, and separated Ginkgolide B derivatives is hydrolyzed in acidic aqueous solution. And the present invention is related to make use it as PAF-antagonistic agent through separating the only one component of the new ginkgolide derivative by those methods.
    Type: Grant
    Filed: July 5, 1994
    Date of Patent: November 14, 1995
    Assignee: Sunkyong Industries Co., Ltd.
    Inventors: Hwa K. Park, Suk K. Lee, Pyeong U. Park, Wie J. Kwan
  • Patent number: 5463085
    Abstract: A synthesis method of physiologically active .delta.-lactone, which comprises addition-reacting diethyl methylmalonate and methacrolein in the presence of a base.
    Type: Grant
    Filed: June 9, 1994
    Date of Patent: October 31, 1995
    Assignee: Nitto Denko Corporation
    Inventors: Tetsuo Omata, Kaichi Tanida
  • Patent number: 5461169
    Abstract: The total synthesis of taxol employs a convergent synthetic plan. The synthetic plan may also be employed to produce a large number of taxol analogs. Taxol analogs having skeletal extensions are inaccessible by modification of the natural product but are readily produced by employing the convergent synthetic plan herein.
    Type: Grant
    Filed: February 16, 1994
    Date of Patent: October 24, 1995
    Assignee: The Scripps Research Institute
    Inventors: K. C. Nicolaou, Zhen Yang, Jin-Jun Liu, Hiroaki Ueno, Philippe G. Nantermet
  • Patent number: 5453519
    Abstract: Dialkylphenylenediamines are used to inhibit oxidation and polymerization of furfural or furfural derivatives. The preferred use of the inhibitor is in the solvent refining of lubricating oils using furfural to extract constituents from the lubricating oils. Prior to and/or during the treatment the acidity of the furfural is adjusted to a level below 0.20 mg KOH/gram furfural.
    Type: Grant
    Filed: March 29, 1994
    Date of Patent: September 26, 1995
    Assignee: Exxon Chemical Patents Inc.
    Inventor: Ghazi Dickakian
  • Patent number: 5453520
    Abstract: Isolation of a new taxane having pharmaceutical activity, 1a 14-beta-hydroxy-10-deacetyl-baccatine III and hemisynthesis of some derivatives useful as antitumor agents and intermediates.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: September 26, 1995
    Assignee: Indena S.p.A.
    Inventors: Ezio Bombardelli, Bruno Gabetta
  • Patent number: 5449793
    Abstract: A novel optically active erythro-1-alkanoyloxy-2,4-O-isopropylidene-2,4-dihydroxy-5-substituted pentane expressed by the formula ##STR1## wherein R.sup.1 represents a halogen atom or cyano group and R.sup.2 represents an alkyl group of 1 to 6 carbon atoms, and a process for producing the above compound are provided, the compound being preferably usable as an intermediate for preparing a HMG-CoA reductase inhibitor and the process being practiced under mild conditions and with a high yield.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: September 12, 1995
    Assignee: Chisso Corporation
    Inventors: Kazutoshi Miyazawa, Teruyo Sugiura, Yasuyuki Koizumi, Naoyuki Yoshida
  • Patent number: 5449790
    Abstract: The present invention relates to a process for converting purified, partially purified or crude taxane mixtures into a protected precursor of 10-deacetylbaccatin III and into 10-deacetylbaccatin III. The process comprises three steps, the first of which includes contacting a mixture containing at least one naturally occurring taxane compound having the structure (II) ##STR1## in which R.sub.1 is phenyl, ##STR2## [an ester linkage at the C-13 position] with at least one hydroxy protecting group. The second step involves cleaving the ester linkage of the protected taxane thus giving rise to a protected precursor of 10-deacetylbaccatin III, the deprotection of which leads to 10-deacetylbaccatin III.
    Type: Grant
    Filed: April 6, 1994
    Date of Patent: September 12, 1995
    Assignee: Hauser Chemical Research, Inc.
    Inventors: Qun Y. Zheng, Christopher K. Murray
  • Patent number: 5447942
    Abstract: The invention relates to a N-(2,4- or 2,5-disubstituted tetrahydrofuryl alkyl)-N-(phenylethyl-.beta.-ol)amine derivative, under a racemic or enantiomer form, of general formula I ##STR1## wherein R represent various radicals and n is of from 1 to 10, to a process for the preparation of said derivative, and to pharmaceutical compositions comprising the same.
    Type: Grant
    Filed: July 13, 1993
    Date of Patent: September 5, 1995
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Serge Auvin, Pierre Braquet, Colette Broquet
  • Patent number: 5442079
    Abstract: There are described improved processes for the synthesis of a desired lactone useful as a synthon, the improved processes comprising oxidizing a protected arene diol with permanganate and periodate or subjecting a substituted epoxydiol to periodate oxidation to yield the desired lactone.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: August 15, 1995
    Assignee: Virginia Polytechnic Institute and State University
    Inventors: Tomas Hudlicky, Martin Mandel
  • Patent number: 5441978
    Abstract: A novel compound having nematicidal effect on pine wood nematodes which has the following structural formula: ##STR1## and a nematicide containing the compound described above against the pine wood nematodes.
    Type: Grant
    Filed: February 3, 1993
    Date of Patent: August 15, 1995
    Assignee: Kioritz Corporation
    Inventor: Takayuki Suga
  • Patent number: 5440054
    Abstract: Described is a novel compound and method, useful for treatment of cardiac arrhythmias, especially useful in patients with congestive heart failure (CHF). A process for synthesizing the novel compound is also described.
    Type: Grant
    Filed: June 16, 1994
    Date of Patent: August 8, 1995
    Assignee: Advanced Therapies, Inc.
    Inventor: Pascal Druzgala
  • Patent number: 5432289
    Abstract: Compounds of formula I ##STR1## wherein R.sub.1 denotes identical or different radicals and is linear or branched C.sub.1 -C.sub.12 alkyl, unsubstituted C.sub.5 -C.sub.6 cycloalkyl or C.sub.5 -C.sub.6 cycloalkyl which is substituted by C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy, or is phenyl or benzyl, or both substituents R.sub.1 of a group (R.sub.1).sub.2 P are o,o'-diphenylene, R.sub.2 is hydrogen, linear or branched C.sub.1 -C.sub.12 alkyl, phenyl or benzyl, R.sub.3 is C.sub.1 -C.sub.12 alkylene, R.sub.4 is C.sub.2 -C.sub.18 alkylene, phenylene or benzylene, and R.sub.5 is C.sub.1 -C.sub.6 alkyl or phenyl, can be applied to solid carriers, such as silica gel or aerosils, and complexed with rhodium or iridium compounds. These materials are heterogeneous and separable catalysts for the asymmetrical hydrogenation of prochiral compounds containing carbon double bonds or carbon/hetero atom double bonds, for example ketones and imines.
    Type: Grant
    Filed: September 9, 1994
    Date of Patent: July 11, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Benoit Pugin, Felix Spindler, Manfred Muller
  • Patent number: 5430160
    Abstract: A process for preparing N-acyl, N-sulfonyl and N-phosphoryl substituted isoserine esters in which a metal or an ammonium alkoxide is reacted with a .beta.-lactam.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: July 4, 1995
    Assignee: Florida State University
    Inventor: Robert A. Holton
  • Patent number: 5428180
    Abstract: A method is provided for oxidizing alkenes to epoxides by treating the alkene with a transition metal ion complex which includes a salen or salophen derivative and peroxymonosulfate ion or hypochlorite ion in a two phase system with a phase transfer catalyst, a water phase having a pH from about 6 to about 12.9 and an inorganic solvent phase in which the complex is sufficiently soluble.
    Type: Grant
    Filed: December 10, 1993
    Date of Patent: June 27, 1995
    Assignee: The Research Foundation of State University of New York
    Inventors: Cynthia Burrows, Thomas R. Wagler, Heungsik Yoon
  • Patent number: 5422364
    Abstract: Alkaline sensitive protaxol is water soluble and is hydrolyzed at physiological (alkaline) pH to render the native taxol structure and the native taxol activity. Protaxol compositions include 2'- and/or 7-O-ester derivatives of taxol and/or 2'- and/or 7-O-carbonate derivatives taxol. Protaxol has a formula as follows: ##STR1## wherein R.sup.1 and R.sup.2 are each H or a radical selected from the group consisting of --CO--(CH.sub.2).sub.m --X--(CH.sub.2).sub.n --COZ and --COO--(CH.sub.2).sub.o --Y--Ar, and wherein m, n, and o are each an integer of 1 to 3; X is O, S, NH, SO, or SO.sub.2 ; Y is S, SO or SO.sub.2 ; Ar is phenyl or substituted phenyl wherein the substituent is halo, amino, nitro or N,N-dialkylamino having 1 to 4 carbons in each of the alkyl groups; and Z is OH, OR.sup.3, SR.sup.3 or NR.sup.4 R.sup.5 wherein R.sup.3 is alkyl containing 1 to 4 carbons and R.sup.4 and R.sup.
    Type: Grant
    Filed: September 16, 1993
    Date of Patent: June 6, 1995
    Assignee: The Scripps Research Institute
    Inventors: K. C. Nicolaou, Claus G. Riemer, Michael A. Kerr
  • Patent number: 5420305
    Abstract: A process for the preparation of a tautomeric mixture of compounds of the formulas ##STR1## wherein W is hydrogen or C.sub.6 H.sub.13, which comprises treating a compound of the formula ##STR2## wherein R is unsubstituted or substituted alkoxy, arylalkoxy, aryloxy or amine and R.sup.1 is hydrogen or when R is alkoxy, substituted alkoxy, substituted amine, unsubstituted or substituted arylalkoxy R.sup.1 can also be metal, with a compound of the formula ##STR3## wherein W is as described above, both X and Y are reducible groups or X is hydrogen and Y is a reducible group or Y is hydrogen and X is a reducible group and, Z is hydroxy or a leaving group to form the compound of formula IV ##STR4## wherein W, X, Y and R are as defined above, the compound of formula IV is treated with a low valent metal to form a tautomeric mixture of compounds of formulas I and Ia, which are useful in the synthesis of tetrahydrolipstatin.
    Type: Grant
    Filed: October 4, 1993
    Date of Patent: May 30, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Keith M. Ramig, John J. Landi, Jr.
  • Patent number: 5420311
    Abstract: This invention relates to novel oxetanes containing neopentyl difluoroamino groups. More specifically, mono- and bis-(difluoroaminomethyl)oxetanes are synthesized. These compounds are prepared by the direct fluorination of blocked neopentyl amines. These mono- and bis-(difluoroaminomethyl)oxetanes can be polymerized to form homopolymers and copolymers with load beating polyether backbones and highly energetic pendant groups. The homopolymers and copolymers of the present invention are useful as energetic binders in high-energy formulations, such as propellants, explosives, and gasifiers.
    Type: Grant
    Filed: June 24, 1993
    Date of Patent: May 30, 1995
    Assignee: Aerojet General Corporation
    Inventors: Thomas G. Archibald, Gerald E. Manser, John E. Immoos
  • Patent number: 5416224
    Abstract: A convenient stereoselective process for the preparation of .alpha.-alkylidene-substituted-.gamma.-butyrolactones and .delta.-valerolactones is provided. The process involves reacting an .alpha.-acyl lactone, an aldehyde, and an alkali metal hydroxide in an inert diluent at an elevated temperature while removing water.
    Type: Grant
    Filed: December 12, 1990
    Date of Patent: May 16, 1995
    Assignee: Henkel Corporation
    Inventor: Louis Rebrovic
  • Patent number: 5416225
    Abstract: The present invention provides two basic routes for the total synthesis of taxol having the structure: ##STR1## The present invention also provides the intermediates produced in the above processes, processes for synthesizing these intermediates as well as analogs to taxol. Both the intermediates and analogs to taxol may prove to be valuable anticancer agents.
    Type: Grant
    Filed: March 30, 1992
    Date of Patent: May 16, 1995
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Samuel J. Danishefsky, William G. Bornmann, Yves Queneau, Thomas V. Magee, Walter J. Krol
  • Patent number: 5412111
    Abstract: Providing a method of preparing (3R,4R)-3-hydroxy-4-hydroxymethyl-4-butanolide conveniently and selectively from a widely available raw material in a high yield. A carbonyl group of the 2-position of levoglucosenone is reduced to obtain a hydroxyl group of a .beta.-configuration. Then, an iodo-group of an .alpha.-configuration and an acyloxy ion of a .beta.-configuration are introduced regioselectively and stereoselectively to the double bond at the 4-position and the 3-position of the above-mentioned levoglucosenone, respectively, keeping a trans stereochemical relationship. An alkoxide is then formed, by hydrolysis and an oxirane ring of a .beta.-configuration is formed by removing an iodo-group by intramolecular nucleophilic displacement reaction of the alkoxide.
    Type: Grant
    Filed: July 23, 1993
    Date of Patent: May 2, 1995
    Assignee: Japan Tobacco Incorporated
    Inventors: Katsuya Matsumoto, Takashi Ebata, Koshi Koseki, Koji Okano, Hiroshi Kawakami, Hajime Matsushita